Previous study showed that only one copy of SPOP allele is mutated in prostate cancer and SPOP mutants exert their tumor-promoting function in a dominant-negative manner to inhibit the wild-type SPOP [2]. This evidence concerns the gene SPOP and prostate carcinoma.